Nextgen Healthcare (NASDAQ:NXGN) Updates FY20 Earnings Guidance

Nextgen Healthcare (NASDAQ:NXGN) issued an update on its FY20 earnings guidance on Thursday morning. The company provided earnings per share guidance of $0.79-0.85 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.85. The company issued revenue guidance of $540-550 million, compared to the consensus revenue estimate of $540.81 million.

Several equities research analysts have recently issued reports on the stock. Jefferies Financial Group set a $16.00 price objective on shares of Nextgen Healthcare and gave the stock a hold rating in a research report on Friday, August 23rd. TheStreet raised shares of Nextgen Healthcare from a c+ rating to a b rating in a research report on Thursday, October 24th. Cantor Fitzgerald cut shares of Nextgen Healthcare from an overweight rating to a neutral rating and decreased their price objective for the stock from $22.00 to $17.00 in a research report on Thursday. They noted that the move was a valuation call. KeyCorp raised shares of Nextgen Healthcare from an underweight rating to a sector weight rating in a research report on Thursday, August 29th. They noted that the move was a valuation call. Finally, Dougherty & Co raised shares of Nextgen Healthcare from a sell rating to a neutral rating and set a $1.00 price objective for the company in a research report on Tuesday, September 17th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company. The stock presently has an average rating of Hold and a consensus price target of $14.86.

NASDAQ:NXGN traded down $1.18 during midday trading on Friday, hitting $15.63. 2,490 shares of the company were exchanged, compared to its average volume of 253,279. The company has a fifty day simple moving average of $17.33 and a 200 day simple moving average of $17.12. Nextgen Healthcare has a fifty-two week low of $13.60 and a fifty-two week high of $21.12. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.11. The company has a market capitalization of $1.19 billion, a PE ratio of 26.23, a price-to-earnings-growth ratio of 3.59 and a beta of 1.07.

Nextgen Healthcare (NASDAQ:NXGN) last announced its quarterly earnings results on Wednesday, October 23rd. The company reported $0.24 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.23 by $0.01. Nextgen Healthcare had a net margin of 3.02% and a return on equity of 10.05%. The firm had revenue of $134.30 million for the quarter, compared to analyst estimates of $134.39 million. During the same period last year, the business earned $0.24 EPS. Nextgen Healthcare’s revenue for the quarter was up 3.1% compared to the same quarter last year. As a group, equities research analysts expect that Nextgen Healthcare will post 0.63 EPS for the current year.

Nextgen Healthcare Company Profile

NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.

See Also: What is the Book Value of a Share?

Earnings History and Estimates for Nextgen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with's FREE daily email newsletter.


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit